Blog

Primary Health Properties PLC (LSE:PHP) has agreed to establish a 50:50 strategic joint venture with global investment firm GIC, initially comprising 27 private hospitals from its existing property portfolio valued at approximately £700 million.

Under the agreement, Primary Health Properties (PHP) will retain a 50% interest in the hospital assets and continue to provide property and asset management services to the joint venture.

The transaction is expected to generate approximately £500 million in net cash proceeds for PHP, which the company intends to use to repay debt associated with its acquisition of Assura and other variable-rate borrowing.

Following the proposed debt repayments, PHP expects group net debt to decline to approximately £2.9 billion.

Joint Venture to Include 27 Private Hospitals

The new joint venture will focus on investment in private hospital infrastructure, with an initial portfolio comprising 27 hospitals currently owned by PHP.

The properties have an aggregate valuation of approximately £700 million.

GIC and PHP will each hold a 50% interest in the venture, providing both parties with exposure to the hospital portfolio.

PHP will remain responsible for property and asset management, generating management fee income alongside its retained ownership interest.

The arrangement will allow PHP to continue participating in the financial performance of the assets while sharing ownership with an institutional investment partner.

The agreement also establishes a platform for potential further investment in private hospital properties.

Approximately £500 Million in Net Cash Proceeds Expected

PHP expects the transaction to generate net cash proceeds of around £500 million.

The company intends to apply these funds towards reducing variable-rate debt, including borrowings incurred in connection with its acquisition of Assura.

The planned repayments include the group’s bridging facility and a £266 million term loan associated with that transaction.

By using the proceeds to repay borrowings, PHP expects to reduce its overall debt balance and exposure to variable interest rates.

The company has identified debt reduction as a principal financial objective of the joint venture transaction.

Net Debt Expected to Fall to £2.9 Billion

Following the proposed application of the proceeds, PHP expects its net debt to decrease to approximately £2.9 billion.

The reduction is also expected to improve the group’s leverage metrics.

PHP said the transaction supports its objective of maintaining a strong investment-grade credit rating.

The anticipated reduction in variable-rate borrowings would also change the composition of the group’s financing arrangements.

The final financial impact will depend on completion of the transaction and the application of the proceeds as planned.

Government-Backed Income Proportion Expected to Exceed 80%

PHP expects the joint venture transaction to increase the proportion of government-backed income across its retained property portfolio to more than 80%.

The change reflects the transfer of a 50% interest in the private hospital assets to the joint venture and the resulting adjustment to the group’s property ownership structure.

PHP’s wider portfolio includes healthcare properties in the United Kingdom and Ireland, with a substantial proportion of rental income supported by government-related healthcare occupiers.

The company focuses on modern healthcare facilities intended to support the delivery of medical services.

Following its combination with Assura in 2025, PHP manages a healthcare property portfolio valued at approximately £6 billion.

PHP to Retain Asset Management Role

In addition to retaining a 50% equity interest, PHP will act as property and asset manager for the hospital joint venture.

This role will provide a fee-based income stream associated with the management of the portfolio.

The arrangement represents an extension of PHP’s existing property management activities through a jointly owned investment structure.

The company will continue to manage its wider healthcare real estate portfolio while participating in the hospital joint venture.

The agreement with GIC also provides a framework for potential future investment in the private hospital sector, although no additional acquisitions have been specified in the supplied announcement.

Transaction Supports Debt Reduction Strategy

The proposed joint venture forms part of PHP’s financial strategy following its acquisition of Assura.

The company expects to receive approximately £500 million in net cash proceeds, reduce net debt to around £2.9 billion and increase the share of government-backed income in its portfolio to more than 80%.

PHP will retain a 50% interest in the initial £700 million hospital portfolio and continue to receive income from its asset management responsibilities.

The supplied update does not specify a completion date or detail any outstanding transaction conditions.

The anticipated financial benefits remain dependent on completion of the joint venture and the planned debt repayments.

Kistos Holdings plc (LSE:KIST) has maintained its full-year 2026 production guidance of 19,000 to 21,000 barrels of oil equivalent per day (boepd), reporting year-to-date pro forma production of approximately 20,000 boepd for the nine months ended 30 September 2026.

Third-quarter production averaged approximately 18,500 boepd, reflecting a planned turnaround of the Jotun floating production, storage and offloading (FPSO) vessel in Norway.

The company also completed its acquisition of Oman Blocks 3 and 4 in September, with the acquisition of Block 9 expected to follow during the fourth quarter.

On an unaudited pro forma basis, Kistos estimated EBITDA of approximately $280 million for the first nine months of 2026, including around $75 million attributable to its Omani operations.

Adjusted net debt increased to $101 million following capital expenditure during the summer and the payment associated with the Oman acquisition.

Third-Quarter Production Averages 18,500 Boepd

Kistos reported pro forma production of approximately 20,000 boepd for the nine months to 30 September 2026.

Output during the third quarter averaged around 18,500 boepd, with the reduction partly attributable to scheduled maintenance on the Jotun FPSO in Norway.

Despite the temporary impact on production, Kistos maintained its full-year guidance range of 19,000 to 21,000 boepd.

The company reported production efficiency exceeding 90% across its principal UK and Dutch assets during the period.

In Norway, additional wells were brought into production, contributing to activity across the group’s existing asset base.

The operational update reflects production across Kistos’ interests in the UK, the Netherlands, Norway and Oman, including the acquired Omani assets on a pro forma basis.

Oman Blocks 3 and 4 Acquisition Completed in September

Kistos completed the acquisition of Oman Blocks 3 and 4 during September, adding producing oil assets to its international portfolio.

The company also expects to complete its acquisition of Oman Block 9 in the fourth quarter of 2026.

The Block 9 transaction remains outstanding, and its expected completion is subject to the relevant transaction arrangements.

Kistos said revised exploration and production sharing agreement (EPSA) terms in Oman have supported an increase in drilling activity.

The company is incorporating the Omani assets into its wider production and development portfolio as it expands its operations beyond its established European markets.

The acquisitions form part of Kistos’ strategy of developing existing assets and pursuing additional oil and gas interests through corporate transactions.

Additional Balder Area Interest Agreed With Vår Energi

Following the end of the reporting period, Kistos agreed to acquire an additional 10% interest in the Balder Area licences in Norway from Vår Energi.

The proposed acquisition would increase Kistos’ participation in the Norwegian assets, subject to regulatory approval.

The Balder Area forms part of the company’s existing Norwegian operations, where production activities include wells connected to the Jotun FPSO.

The additional interest has not yet transferred, and completion remains conditional on the necessary regulatory consent.

Kistos has not provided a confirmed completion date for the transaction in the supplied update.

Unaudited Pro Forma EBITDA Estimated at $280 Million

Kistos estimated unaudited pro forma EBITDA of approximately $280 million for the nine months ended 30 September 2026.

The figure includes an estimated contribution of around $75 million from the Omani assets.

The company reported that realised oil and gas prices supported earnings during the period.

The EBITDA figures are presented on a pro forma basis and are unaudited, reflecting the inclusion of assets acquired during the year.

Kistos also highlighted the pricing arrangements associated with Omani oil offtake agreements.

According to the company, these arrangements incorporate a lag between prevailing market prices and realised sales prices, which could moderate the immediate effect of changes in oil prices on revenue.

The impact of this pricing structure will depend on future commodity price movements and the terms of the relevant sales arrangements.

Adjusted Net Debt Rises to $101 Million

Kistos reported adjusted net debt of $101 million at the end of September.

The increase reflected capital expenditure during the summer and the payment associated with the acquisition of Oman Blocks 3 and 4.

The company continues to allocate capital towards production operations, development activities and acquisitions across its portfolio.

Its financial position will be influenced by operating cash generation, commodity prices, capital expenditure and the completion of outstanding transactions.

Full-Year Guidance Reaffirmed

Kistos maintained its 2026 production guidance of 19,000 to 21,000 boepd following the third-quarter operational update.

The company expects to continue production activities across its European and Omani assets while progressing the planned acquisition of Block 9 and the additional Balder Area interest.

The Block 9 acquisition is expected to complete during the fourth quarter, while the Balder transaction remains subject to regulatory approval.

Kistos enters the final quarter of 2026 with year-to-date pro forma production of approximately 20,000 boepd, estimated unaudited pro forma EBITDA of $280 million and adjusted net debt of $101 million.

LondonMetric Property Plc (LSE:LMP) reported an increase of more than 8% in net rental income to approximately £240 million for the six months ended 30 September 2026, supported by acquisitions, rent reviews and asset management activity.

The UK-listed real estate investment trust (REIT) recorded 5.8% growth in like-for-like annualised rental income, while rent collection reached 99.3% during the period.

The company also announced a further increase in its dividend, continuing its policy of progressive shareholder distributions.

LondonMetric said earnings remained in line with analysts’ expectations, supported by income from its existing property portfolio and the contribution of acquisitions, including Urban Logistics REIT and Picton.

The group continued to adjust its property holdings through £185 million of disposals and £424 million of acquisitions, primarily involving logistics and long-let convenience assets.

Net Rental Income Exceeds £240 Million

LondonMetric reported net rental income of approximately £240 million for the first half of its financial year, representing growth of more than 8% compared with the corresponding period.

Like-for-like annualised rental income increased by 5.8%, reflecting rental growth within the existing portfolio.

The company maintained a rent collection rate of 99.3%, supported by its portfolio of income-producing properties.

LondonMetric attributed its rental income performance to high occupancy, long lease terms and rent reviews, alongside contributions from previously acquired assets.

The integration of Urban Logistics REIT, acquired in the previous year, and the Picton takeover contributed to the group’s expanded property portfolio.

The company said its earnings performance remained consistent with analysts’ expectations for the period.

£424 Million of Acquisitions and £185 Million of Disposals

LondonMetric continued its programme of portfolio recycling during the six months to September.

The company completed £424 million of property acquisitions, concentrating investment on logistics and long-let convenience assets.

These purchases were accompanied by £185 million of disposals involving properties identified as non-core to the group’s portfolio strategy.

The disposals were completed at book value, according to the company.

The transactions form part of LondonMetric’s approach to reallocating capital towards properties that meet its investment criteria, including lease duration, rental income characteristics and occupier demand.

Further acquisitions and lettings remained under offer at the end of the reporting period.

Asset Management Generates £11.8 Million in Additional Annual Rent

LondonMetric reported that asset management initiatives generated £11.8 million of additional annual rental income.

These activities included rent reviews and other measures intended to increase income from existing properties.

The company continues to manage its portfolio through lease arrangements, rental adjustments and selective investment activity.

Its property holdings are concentrated in logistics, healthcare, convenience, entertainment and leisure sectors.

The group operates a triple net lease investment model, under which tenants typically assume responsibility for specified property operating costs, including maintenance, insurance and taxes, depending on the relevant lease terms.

This structure forms part of LondonMetric’s focus on long-term contracted rental income.

Portfolio Valuation Remains Stable

LondonMetric reported that its property portfolio valuation remained broadly unchanged during the period.

The company also highlighted higher interest rate swap costs, reflecting the financing environment affecting its operations.

Despite these costs, the group maintained its portfolio valuation while continuing to complete acquisitions and disposals.

LondonMetric’s property platform is valued at approximately £8 billion and includes assets across several commercial property sectors.

The company continues to focus on properties with long lease terms and established rental income streams.

Dividend Increased as Earnings Remain in Line With Expectations

LondonMetric announced a further increase in its dividend for the reporting period, extending its record of progressive distributions.

The company said its earnings remained in line with analysts’ expectations and indicated that its prospective dividend was fully covered.

The supplied update does not specify the latest dividend per share or the percentage increase from the previous period.

LondonMetric continues to pursue income growth through rent reviews, asset management and investment in long-let properties.

The company ended the six-month period with approximately £240 million in net rental income, 5.8% like-for-like annualised rental growth and 99.3% rent collection.

Its near-term activities include completing further lettings and potential acquisitions while continuing to manage its existing property portfolio and financing arrangements.

Invinity Energy Systems plc (LSE:IES) has announced plans to raise at least £20 million through a combination of a share subscription, institutional placing and retail offer, with all new ordinary shares priced at 10 pence each.

The AIM-listed manufacturer of vanadium flow battery systems has entered an AIM Capital Access Window to facilitate the proposed fundraising process, resulting in a temporary suspension of trading in its ordinary shares.

The company said the proposed capital raising is intended to support its financial position and further commercial development in the long-duration energy storage market.

The fundraising remains subject to completion of the relevant processes and shareholder approval.

Proposed Fundraise Combines Subscription, Placing and Retail Offer

Invinity intends to raise a minimum of £20 million through three components: a subscription for new ordinary shares, an institutional placing and an offer to retail investors.

All three components are proposed at an issue price of 10 pence per new ordinary share.

At that price, raising £20 million would require the issuance of at least 200 million new ordinary shares, before any associated expenses.

The final number of shares issued will depend on the total amount raised through the proposed transaction.

The company has not provided a final allocation between the subscription, institutional placing and retail offer in the supplied announcement.

The fundraising is intended to provide additional capital for Invinity’s operations and commercial development activities.

AIM Capital Access Window Introduced During Fundraising

Invinity has entered an AIM Capital Access Window in connection with the proposed share issue.

Under this arrangement, trading in the company’s ordinary shares has been temporarily suspended while the fundraising process is undertaken.

The suspension is intended to facilitate the capital raising and associated shareholder approval process.

Trading is expected to remain suspended until the relevant fundraising arrangements have been concluded and the required shareholder approval has been obtained.

The company has not specified a confirmed date for the resumption of trading.

Completion of the proposed fundraise remains conditional, and the announcement does not establish that the targeted proceeds have been secured.

Endurium Batteries Target Long-Duration Energy Storage

Invinity develops and manufactures vanadium flow battery systems designed for long-duration electricity storage.

Its Endurium product range is intended for applications requiring repeated charging and discharging over extended operating periods.

The systems are designed to support electricity networks, renewable energy projects and commercial and industrial customers requiring energy storage capacity.

Unlike lithium-ion batteries, vanadium flow batteries use liquid electrolytes containing vanadium to store energy.

Invinity markets its technology as a non-flammable storage alternative designed for high-throughput applications and extended service life.

The company’s Endurium systems are engineered for an operating life of approximately 30 years.

Manufacturing Operations in the UK and Canada

Invinity operates battery manufacturing facilities in the United Kingdom and Canada, supporting the production and development of its energy storage systems.

The company supplies technology intended to help electricity customers manage fluctuations in renewable generation and provide stored power when required.

Its systems have been deployed in multiple markets, with the company reporting that its installed technology has delivered gigawatt-hours of electricity to customers worldwide.

Invinity’s commercial activities focus on utility-scale storage, renewable energy integration and commercial and industrial applications.

The proposed fundraising forms part of its efforts to support these operations and pursue further deployment opportunities.

Fundraising Remains Subject to Shareholder Approval

The proposed transaction would provide Invinity with at least £20 million in gross proceeds if completed at the stated minimum amount.

However, the final fundraising outcome remains subject to investor participation, completion of the relevant transaction arrangements and shareholder approval.

The issuance of new ordinary shares would also increase the company’s share capital, resulting in dilution for existing shareholders who do not participate.

Invinity has not disclosed a confirmed timetable for completion or the resumption of trading in the supplied update.

The company will continue progressing the proposed fundraising while its shares remain suspended under the AIM Capital Access Window.

Petro Matad Limited (LSE:MATD) has announced that its SunSteppe Power subsidiary has signed a cooperation memorandum of understanding (MoU) with Saudi-listed energy developer Acwa to pursue a renewable electricity export project connecting Mongolia and China.

The proposed first phase targets 4.5 gigawatts (GW) of renewable energy generation capacity, supported by 500 megawatt-hours (MWh) of battery energy storage.

The agreement forms part of Petro Matad’s expansion into renewable energy through its 50%-owned SunSteppe Renewable Energy joint venture, alongside its existing oil exploration and production operations in Mongolia.

Separately, SunSteppe has identified a portfolio of renewable energy projects totalling 570 megawatts (MW), with potential development premia estimated at approximately $20 million to $30 million between 2027 and 2029.

Acwa Agreement Targets Cross-Border Electricity Exports

Under the cooperation MoU, SunSteppe Power and Acwa intend to explore the development of renewable electricity generation in Mongolia for export to China.

The initial phase of the proposed initiative would involve 4.5 GW of generation capacity and 500 MWh of battery storage.

The project is intended to utilise Mongolia’s solar and wind resources and its geographical proximity to China to support cross-border electricity supply.

The cooperation arrangement represents an early stage in the proposed development. The supplied announcement does not specify a construction timetable, investment commitment or agreed electricity offtake arrangements.

Further development would require the parties to progress technical, commercial and regulatory matters associated with renewable generation and cross-border power transmission.

SunSteppe Renewable Energy Portfolio Reaches 570 MW

SunSteppe Renewable Energy has assembled a portfolio of four renewable energy projects with a combined planned capacity of 570 MW.

The portfolio comprises three solar generation projects incorporating battery storage and one hybrid project combining wind, solar and battery technologies.

The joint venture estimates that these projects could generate development premia of approximately $20 million to $30 million over the period from 2027 to 2029.

These amounts represent potential future development proceeds rather than contracted revenue or realised earnings.

The portfolio forms part of SunSteppe’s strategy to develop renewable energy assets in Mongolia, including projects that could be advanced with external development or investment partners.

Additional 124 MW of Projects Under Consideration

Beyond its existing 570 MW portfolio, SunSteppe has identified a further 124 MW of potential renewable energy development opportunities.

These include a green hydrogen project associated with OT, which has access to Japanese grant funding.

The company is assessing these projects as potential additions to its renewable energy development pipeline.

SunSteppe has also identified off-grid electricity supply to Mongolia’s mining sector as a potential market exceeding 500 MW.

Mining operations in Mongolia represent a prospective customer base for renewable generation and storage systems, including facilities operating away from established electricity networks.

The identified market opportunity does not represent contracted generating capacity, and no associated customer agreements or revenue figures were disclosed in the supplied update.

Renewable Energy Activities Complement Mongolian Oil Operations

Petro Matad is an AIM-listed exploration and production company with oil interests in Mongolia.

The group holds 100% working interests and operatorship in the Matad Block XX and Borzon Block VII production sharing contracts.

Its 50% ownership of SunSteppe Renewable Energy provides exposure to renewable power development alongside these hydrocarbon activities.

Through SunSteppe, the company is pursuing utility-scale solar, wind and battery storage projects, as well as opportunities in green hydrogen and electricity supply for industrial customers.

The cooperation agreement with Acwa introduces a potential cross-border export initiative alongside the joint venture’s existing domestic project portfolio.

Development Timetables and Commercial Agreements Remain Outstanding

The proposed 4.5 GW renewable electricity export initiative remains at the cooperation MoU stage, with further agreements and development work required before implementation.

SunSteppe’s existing 570 MW project portfolio and additional 124 MW pipeline also remain subject to their respective development processes.

Petro Matad has identified potential development premia of $20 million to $30 million between 2027 and 2029, although the timing and realisation of those proceeds will depend on project progress and commercial arrangements.

The company will continue pursuing its renewable energy development activities through SunSteppe while maintaining its existing oil interests in Mongolia.

Tristel plc (LSE:TSTL) reported a 10% increase in annual revenue to £51.1 million, alongside a 15% rise in adjusted pre-tax profit to £11.7 million, supported by higher sales across its principal markets, including an increased contribution from the United States.

The AIM-listed infection prevention specialist maintained a gross profit margin of 82% during the financial year and increased its full-year dividend by 5%.

Tristel ended the reporting period with £16.0 million in cash and short-term investments and no outstanding debt.

The company also completed its transition to in-house wipe manufacturing, introduced new cleaning and digital compliance products, and appointed Chris Lee as chief executive officer.

Revenue Growth Across UK, European and US Markets

Tristel reported increased sales in the United Kingdom and Europe, alongside a larger revenue contribution from its US operations.

The company attributed part of its US growth to increased adoption of its Tristel ULT and Tristel OPH products, which form part of its medical device decontamination portfolio.

Tristel also highlighted the expansion of US clinical guidelines supporting the use of chlorine dioxide technology, the chemical basis of its disinfectant products.

The group develops and supplies infection prevention products for healthcare settings, including solutions used in the manual decontamination of medical devices and sporicidal surface disinfection.

Its operations extend across more than 40 countries through a network of 16 subsidiaries and distribution arrangements.

The increased contribution from the United States forms part of Tristel’s ongoing international expansion strategy.

Adjusted Pre-Tax Profit Increases 15% to £11.7 Million

Tristel reported adjusted pre-tax profit of £11.7 million, representing a 15% increase from the previous financial year.

Revenue rose by 10% to £51.1 million, while the gross profit margin remained at 82%.

The company maintained its focus on profitability alongside revenue expansion, supported by its established disinfectant product portfolio and international operations.

Tristel has a stated objective of achieving double-digit annual revenue growth while maintaining an adjusted EBITDA margin of at least 25%.

The company did not provide an adjusted EBITDA figure for the reporting period in the supplied update.

In-House Wipe Manufacturing Transition Completed

During the financial year, Tristel completed its transition to manufacturing wipes internally.

The move represents a change in the group’s production arrangements, bringing wipe manufacturing operations within the business rather than relying on external production.

The company also introduced VISICLEAN, a cleaning technology developed as part of its infection prevention product offering.

These developments form part of Tristel’s ongoing investment in manufacturing capabilities and product development.

The supplied update does not quantify the financial contribution from VISICLEAN or the impact of the manufacturing transition on operating costs.

3T Pro Introduced as First Paid Digital Compliance Platform

Tristel expanded its digital product offering with the launch of 3T Pro, its first paid digital compliance platform.

The product is intended to support healthcare customers with compliance-related processes associated with infection prevention and decontamination activities.

The launch introduces a paid digital service alongside Tristel’s existing disinfectant and cleaning product portfolio.

The company has identified digital services as an area for future development, with the aim of expanding its revenue sources beyond physical infection prevention products.

No revenue contribution or subscriber figures for 3T Pro were disclosed in the supplied update.

Chris Lee Appointed Chief Executive Officer

Tristel appointed Chris Lee as chief executive officer during the period.

The company identified international expansion and the development of digital revenue as priorities under the new leadership.

Lee brings previous industry experience to the role and will oversee the group’s continued development across its established and emerging markets.

Tristel operates from its headquarters near Cambridge and employs approximately 280 people across its international business.

Full-Year Dividend Increased by 5%

Tristel increased its full-year dividend by 5%, continuing its policy of progressive shareholder distributions.

The company ended the financial year with £16.0 million in cash and short-term investments and no debt.

Its financial position reflects the group’s reported profitability and cash holdings at the end of the period.

The company continues to pursue its stated financial objectives of double-digit annual revenue growth and an adjusted EBITDA margin of at least 25%.

Tristel’s operational priorities include expanding its US business, developing its digital compliance offering and integrating its in-house manufacturing activities.

The company enters its next financial year following revenue growth across its principal markets, the introduction of additional products and changes to its manufacturing and management structure.

City of London Investment Group PLC (LSE:CLIG) reported a decline in funds under management (FuM) to $11.5 billion for the quarter ended 30 September 2026, reflecting net client outflows and adverse market movements across its investment portfolios.

The asset management group recorded net outflows of $667 million during the three-month period, while market movements reduced assets by a further $127 million.

The company attributed much of the outflow activity to portfolio rebalancing by clients following investment performance, particularly within its emerging markets and international equity strategies.

Both of the group’s principal investment management businesses, City of London Investment Management (CLIM) and Karpus Investment Management (KIM), reported reductions in funds under management during the quarter.

Separately, the group has proposed increasing its total dividend for the 2026 financial year to 34 pence per share.

Client Withdrawals and Market Movements Reduce Assets

City of London Investment Group reported combined net client outflows of $667 million during the quarter, alongside a $127 million reduction attributable to market movements.

The company said client portfolio adjustments were a principal factor behind the withdrawals, with investors rebalancing allocations following previous investment performance.

The activity was particularly evident in emerging markets and international equity portfolios, which form part of the group’s investment management offering.

The combined impact of client withdrawals and market movements reduced total funds under management to $11.5 billion at 30 September 2026.

The group manages investments across equity, fixed income and balanced portfolio strategies for institutional and wealth management clients.

CLIM Funds Under Management Decline to $7.4 Billion

City of London Investment Management, the group’s investment management division, reported a reduction in funds under management from $8.1 billion to $7.4 billion during the quarter.

The decline reflected client withdrawals and market-related changes, with emerging markets and international equity strategies particularly affected by portfolio rebalancing.

CLIM provides investment management services across a range of equity strategies, including emerging markets and international portfolios.

The company said client allocation decisions following investment performance contributed to the reduction in assets.

The division continues to operate within the group’s broader investment management structure, which serves institutional investors and other professional clients.

Karpus Investment Management Assets Fall to $4.1 Billion

Karpus Investment Management, the group’s US-based investment management business, reported funds under management of $4.1 billion at the end of September, compared with $4.3 billion at the beginning of the quarter.

The reduction reflected changes in client allocations within balanced investment mandates, together with modestly negative market movements.

KIM provides investment management services that include balanced portfolios and tax-sensitive fixed income strategies.

The division’s quarterly asset movements contributed to the overall reduction in group funds under management.

Group Plans Additional Sales and Marketing Activity

City of London Investment Group said it is increasing sales, marketing and investment research-related communications to support awareness of its investment capabilities.

The initiatives are intended to increase recognition of the group’s fixed income and equity strategies among existing and prospective clients.

The company continues to offer investment products across emerging markets, international equities, balanced portfolios and fixed income.

Management also highlighted the group’s long-term investment performance record and the range of strategies available through CLIM and KIM.

The planned commercial activity forms part of its efforts to develop client relationships and attract additional investment allocations.

Proposed FY2026 Dividend Increased to 34 Pence Per Share

Despite the reduction in funds under management during the September quarter, City of London Investment Group has proposed a total dividend of 34 pence per share for the 2026 financial year.

The proposed distribution represents an increase in the group’s annual dividend, although the supplied update does not specify the previous year’s total payment.

The dividend proposal comes alongside the group’s quarterly funds under management update and its plans to expand marketing and client development activities.

City of London Investment Group ended September 2026 with $11.5 billion in funds under management across its two investment management businesses.

Future asset levels will depend on client subscriptions and withdrawals, investment portfolio valuations and market movements, while the group continues implementing its sales and marketing initiatives.

Sunda Energy Plc (LSE:SNDA) has received a 12-month extension to the current phase of its TL-SO-19-16 production sharing contract (PSC) in Timor-Leste, which contains the Chuditch gas field.

The extension was granted by Timor-Leste’s upstream petroleum regulator, Autoridade Nacional do Petróleo (ANP), following an earlier notice of possible termination after the joint venture failed to drill the planned Chuditch-2 appraisal well by the June 2026 deadline.

The regulatory decision provides additional time for Sunda and its joint venture partner, state-owned TIMOR GAP, to progress discussions concerning the project’s ownership structure, potential third-party investment and future operatorship arrangements.

Under the revised terms, drilling-cost recovery uplifts will remain suspended until operations on the Chuditch-2 well commence.

PSC Extension Follows Missed June 2026 Drilling Deadline

The TL-SO-19-16 production sharing contract covers the Chuditch gas field offshore Timor-Leste, where Sunda is pursuing an appraisal programme through its wholly owned subsidiary, SundaGas Banda Unipessoal, Lda.

The joint venture had been required to drill the Chuditch-2 appraisal well by June 2026 but did not meet that deadline.

Following the missed commitment, ANP issued a notice indicating that the production sharing contract could be terminated.

The regulator has now granted a 12-month extension to the current contract phase, allowing the joint venture additional time to progress the appraisal programme.

The extension maintains the contractual framework for the project during the revised period, although the drilling commitment remains outstanding.

The company has not announced a confirmed commencement date for Chuditch-2 drilling.

Farm-In and Operatorship Discussions Continue

Sunda and TIMOR GAP are continuing discussions regarding potential changes to the commercial and operational structure of the Chuditch project.

The matters under consideration include a possible farm-in transaction, increased participation by the Timor-Leste state and the transfer of operatorship.

A farm-in arrangement would involve another party acquiring an interest in the project under terms to be agreed between the relevant participants.

The proposed changes remain under discussion, and Sunda has not confirmed that binding agreements have been reached.

The company said the additional time provided by the PSC extension will allow these negotiations to continue alongside preparations for the Chuditch-2 appraisal well.

Drilling-Cost Recovery Uplifts Suspended Until Operations Begin

As part of the revised contractual arrangements, drilling-cost recovery uplifts will be suspended until operations commence on Chuditch-2.

The suspension affects the treatment of eligible drilling expenditure under the production sharing contract during the period before the appraisal well begins.

The company has not provided a quantified financial impact from the suspension in the supplied update.

The arrangement forms part of the terms associated with the extension granted by ANP.

Sunda Coordinates Potential Drilling Schedule With Finder Energy

Sunda is also working with Finder Energy to assess opportunities for coordinating the Chuditch-2 drilling programme with other exploration and appraisal activity in Timor-Leste.

Finder Energy has secured a drilling rig with optional slots that could potentially be used to accommodate the Chuditch-2 well.

The companies are examining whether aligning their drilling programmes could provide operational and cost efficiencies through shared scheduling and related arrangements.

Any coordination remains dependent on the availability of suitable rig slots and agreement on the relevant operational requirements.

Sunda has not confirmed a rig contract or final drilling timetable for Chuditch-2.

Chuditch Appraisal Remains Central to Sunda’s Development Plans

Sunda Energy is an AIM-listed gas exploration and appraisal company focused on opportunities in the Asia-Pacific region.

Its activities in Timor-Leste are conducted through SundaGas Banda Unipessoal, Lda., in partnership with TIMOR GAP.

The Chuditch-2 well is intended to provide additional subsurface information to support the evaluation of the Chuditch gas field.

The 12-month PSC extension allows Sunda to continue progressing the project while discussions on potential investment, state participation and operatorship remain ongoing.

The company’s next steps include advancing those negotiations, coordinating potential drilling arrangements with Finder Energy and establishing a revised schedule for Chuditch-2.

The appraisal well has not yet commenced, and the proposed changes to the joint venture structure remain subject to further agreement.

Nuformix plc (LSE:NFX) has reported further preclinical findings for NXP002, its investigational inhaled treatment for idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis and related interstitial lung diseases.

The company’s latest pilot inhaled target engagement study found statistically significant changes in the TGF-β/SMAD signalling pathway, which is involved in the development and progression of pulmonary fibrosis.

Nuformix said the study showed suppression of the phosphorylated SMAD-to-total SMAD (pSMAD/SMAD) ratio, including at the lowest dose tested. Significant reductions were observed across multiple doses and timepoints.

The results add to earlier α-smooth muscle actin (α-SMA) biomarker findings and form part of the company’s ongoing investigation into the biological activity of NXP002.

The findings are preclinical and do not establish clinical efficacy or safety in patients.

Study Examines NXP002’s Effect on Fibrosis-Related Signalling

The pilot study evaluated whether inhaled NXP002 could affect activity in the TGF-β/SMAD signalling pathway.

Nuformix reported statistically significant suppression of the pSMAD/SMAD ratio at several dose levels and measurement points, including at the lowest dose tested.

The company is investigating this pathway because of its involvement in fibrotic processes in the lungs.

The latest results complement earlier α-SMA biomarker data, which also formed part of the programme’s assessment of fibrosis-related biological activity.

Nuformix said the combined findings, alongside previously reported exposure data, are being used to inform the selection of biologically relevant dose ranges for further development.

The supplied update does not disclose the study’s sample size, numerical effect sizes or detailed statistical results.

NXP002 Development Moves Towards IND-Enabling Studies

Nuformix is convening an expert advisory board to help guide the next stage of NXP002’s development.

The company intends to advance the programme towards investigational new drug (IND)-enabling studies, which would support preparation for potential clinical testing.

NXP002 is an inhaled formulation of tranilast, being developed for IPF, progressive pulmonary fibrosis and other progressive fibrosing interstitial lung diseases.

The programme is intended to investigate whether delivering tranilast through inhalation can provide lung-targeted exposure for the treatment of fibrotic lung conditions.

Nuformix has also begun work with a target discovery platform to investigate additional molecular targets that may contribute to NXP002’s anti-fibrotic activity.

The research is intended to broaden the company’s understanding of the candidate’s mechanisms of action and assess whether it affects multiple pathways associated with fibrosis.

Partnering Discussions Continue Following Respiratory Congress Meetings

Nuformix said it held meetings with prospective development and licensing partners at the European Respiratory Society Congress.

The company described the discussions as encouraging and said the additional preclinical findings would contribute to its ongoing partnering activities.

The programme’s development rationale is based on its preclinical exposure, biomarker and pathway data, together with further work to investigate its biological effects.

Nuformix said it has sufficient capital to complete its current programme of work.

The company has not announced a licensing agreement or disclosed financial terms for any potential partnership.

Further Research Required to Establish Clinical Potential

NXP002 remains at the preclinical development stage. The latest study provides evidence of modulation of a fibrosis-related signalling pathway, but further research will be needed to assess the candidate’s safety, efficacy and suitability for clinical development.

Nuformix plans to use the new findings, previous exposure data and input from its expert advisory board to inform the next phase of the programme.

The company’s ongoing work includes investigating additional molecular targets, refining dose selection and progressing towards IND-enabling studies.